Panax notoginseng Saponins Improve Angiogenesis in Coronary Heart Disease Based on the microRNA 200a Methylation Pathway [Retraction]

Wang J, Dong Y, Li Z, et al. Drug Des Devel Ther. 2024;18:6075—6087. We, the Editors and Publisher of the journal Drug Design, Development and Therapy have retracted the published article. After publication, concerns have been raised by a third party about the integrity of the data in the article. Further investigations conducted by the Journal and Publisher confirmed duplicate image panels representative of different treatment conditions present in Figure 4C of the article. Additional article integrity concerns were identified due to inconsistencies in the reported methodology and animal experiments. When approached for an explanation, the authors have provided their raw data for Figure 4C, but have not been able to address the additional methodological concerns and the ethical concerns regarding the animal studies conducted. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-09-12
Primary Topic
Insurance, Mortality, Demography, Risk Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Panax notoginseng Saponins Improve Angiogenesis in Coronary Heart Disease Based on the microRNA 200a Methylation Pathway [Retraction]

Dove Medical Press (Taylor and Francis Group)
Insurance, Mortality, Demography, Risk Management
article

Panax notoginseng Saponins Improve Angiogenesis in Coronary Heart Disease Based on the microRNA 200a Methylation Pathway [Retraction]

article en

Abstract

Wang J, Dong Y, Li Z, et al. Drug Des Devel Ther. 2024;18:6075—6087. We, the Editors and Publisher of the journal Drug Design, Development and Therapy have retracted the published article. After publication, concerns have been raised by a third party about the integrity of the data in the article. Further investigations conducted by the Journal and Publisher confirmed duplicate image panels representative of different treatment conditions present in Figure 4C of the article. Additional article integrity concerns were identified due to inconsistencies in the reported methodology and animal experiments. When approached for an explanation, the authors have provided their raw data for Figure 4C, but have not been able to address the additional methodological concerns and the ethical concerns regarding the animal studies conducted. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 28%
Insurance, Mortality, Demography, Risk Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.